Biomarkers to measure treatment effects in Alzheimer's disease: What should we look for?

International Journal of Alzheimer's Disease

Volumn , Issue , 2011, Pages

  Rockwood, Kenneth ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ALZHEIMER DISEASE; COGNITIVE DEFECT; HUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; REVIEW;

EID: 84855275524     PISSN: None     EISSN: 20900252     Source Type: Journal    
DOI: 10.4061/2011/598175     Document Type: Review

References (20)

1. Rockwood K., Fay S., Gorman M., The ADAS-cog and clinically meaningful change in the VISTA clinical trial of galantamine for Alzheimer's disease International Journal of Geriatric Psychiatry 2010 25 2 191 201
2. Robert P., Ferris S., Gauthier S., Ihl R., Winblad B., Tennigkeit F., Review of Alzheimer's disease scales: is there a need for a new multi-domain scale for therapy evaluation in medical practice? Alzheimer's Research and Therapy 2010 2 4, article 24
3. Atkinson A. J. Jr., Colburn W. A., DeGruttola V. G., DeMets D. L., Downing G. J., Hoth D. F., Oates J. A., Peck C. C., Schooley R. T., Spilker B. A., Woodcock J., Zeger S. L., Biomarkers and surrogate endpoints: preferred definitions and conceptual framework Clinical Pharmacology and Therapeutics 2001 69 3 89 95 (Pubitemid 32225406)
4. Rockwood K., Macknight C., Assessing the clinical importance of statistically significant improvement in anti-dementia drug trials Neuroepidemiology 2001 20 2 51 56 (Pubitemid 32453721)
5. Hill A. B., A Short Textbook of Medical Statistics 1984 London, UK Hodder and Stoughton
6. Basi G. S., Hemphill S., Brigham E. F., Liao A., Aubele D. L., Baker J., Barbour R., Bova M., Chen X. H., Dappen M. S., Eichenbaum T., Goldbach E., Hawkinson J., Lawler Herbold R., Hu K., Hui T., Jagodzinski J. J., Keim P. S., Kholodenko D., Latimer L. H., Lee M., Marugg J., Mattson M. N., McCauley S., Miller J. L., Motter R., Mutter L., Neitzel M. L., Ni H., Nguyen L., Quinn K., Ruslim L., Semko C. M., Shapiro P., Smith J., Soriano F., Szoke B., Tanaka K., Tang P., Tucker J. A., Ye X. M., Yu M., Wu J., Zu Y. Z., Garofalo A. W., Sauer J. M., Konradi A. W., Ness D., Shopp G., Pleiss M. A., Freedman S. B., Schenk D., Amyloid precursor protein selective gamma-secretase inhibitors for treatment of Alzheimer's disease Alzheimer's Research amp; Therapy 2010 2 6, article 36
7. Song X., Mitnitski A., Rockwood K., Non-traditional risk factors combine to predict Alzheimers disease and dementia Neurology 2011 77 3 227 234
8. Savva G. M., Wharton S. B., Ince P. G., Forster G., Matthews F. E., Brayne C., Age, neuropathology, and dementia The New England Journal of Medicine 2009 360 22 2302 2309
9. White L., Brain lesions at autopsy in older japanese-american men as related to cognitive impairment and dementia in the final years of life: a summary report from the honolulu-asia aging study Journal of Alzheimer's Disease 2009 18 3 713 725
10. Dubois B., Feldman H. H., Jacova C., DeKosky S. T., Barberger-Gateau P., Cummings J., Delacourte A., Galasko D., Gauthier S., Jicha G., Meguro K., O'Brien J., Pasquier F., Robert P., Rossor M., Salloway S., Stern Y., Visser P. J., Scheltens P., Research criteria for the diagnosis of Alzheimer's disease: revising the NINCDS-ADRDA criteria The Lancet Neurology 2007 6 8 734 746 (Pubitemid 47058377)
11. Gomar J. J., Bobes-Bascaran M. T., Conejero-Goldberg C., Davies P., Goldberg T. E., Utility of combinations of biomarkers, cognitive markers, and risk factors to predict conversion from mild cognitive impairment to Alzheimer disease in patients in the Alzheimer's disease neuroimaging initiative Archives of General Psychiatry 2011 68 9 961 969
12. Sperling R. A., Aisen P. S., Beckett L. A., Bennett D. A., Craft S., Fagan A. M., Iwatsubo T., Jack C. R. Jr., Kaye J., Montine T. J., Park D. C., Reiman E. M., Rowe C. C., Siemers E., Stern Y., Yaffe K., Carrillo M. C., Thies B., Morrison-Bogorad M., Wagster M. V., Phelps C. H., Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease Alzheimer's and Dementia 2011 7 3 280 292
13. Frisoni G. B., Fox N. C., Jack C. R., Scheltens P., Thompson P. M., The clinical use of structural MRI in Alzheimer disease Nature Reviews Neurology 2010 6 2 67 77
14. Karlawish J., The meaning of Alzheimers disease across time and place Alzheimers and Dementia 2010 4, article S86
15. Erickson K. I., Voss M. W., Prakash R. S., Basak C., Szabo A., Chaddock L., Kim J. S., Heo S., Alves H., White S. M., Wojcicki T. R., Mailey E., Vieira V. J., Martin S. A., Pence B. D., Woods J. A., McAuley E., Kramer A. F., Exercise training increases size of hippocampus and improves memory Proceedings of the National Academy of Sciences of the United States of America 2011 108 7 3017 3022
16. Barnes J., Ourselin S., Fox N. C., Clinical application of measurement of hippocampal atrophy in degenerative dementias Hippocampus 2009 19 6 510 516
17. Imhof A., Kvari E., von Gunten A., Gold G., Rivara C. B., Herrmann F. R., Hof P. R., Bouras C., Giannakopoulos P., Morphological substrates of cognitive decline in nonagenarians and centenarians: a new paradigm? Journal of the Neurological Sciences 2007 257 1-2 72 79 (Pubitemid 46876646)
18. Bennett D. A., Schneider J. A., Bienias J. L., Evans D. A., Wilson R. S., Mild cognitive impairment is related to Alzheimer disease pathology and cerebral infarctions Neurology 2005 64 5 834 841 (Pubitemid 40316322)
19. Schneider L. S., Kennedy R. E., Cutter G. R., Requiring an amyloid- 1-42 biomarker for prodromal Alzheimer's disease or mild cognitive impairment does not lead to more efficient clinical trials Alzheimer's and Dementia 2010 6 5 367 377
20. Shaw L. M., Vanderstichele H., Knapik-Czajka M., Clark C. M., Aisen P. S., Petersen R. C., Blennow K., Soares H., Simon A., Lewczuk P., Dean R., Siemers E., Potter W., Lee V. M.Y., Trojanowski J. Q., Cerebrospinal fluid biomarker signature in alzheimer's disease neuroimaging initiative subjects Annals of Neurology 2009 65 4 403 413